03.22.2024 - By ABC listen
In this small study, brain cancer tumours shrank rapidly in the first few days when treated with chimeric antigen receptor, or CAR, T cells injected into the fluid around the brain.
While some tumours returned in time, Dr Marcela Maus, from Harvard Medical School, says it's a proof of concept that requires further study.